Ramil Goel is a Cardiology physician affiliated with Santa Fe College. OpenAlex indexes 56 publications with 356 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-273-9079Registry record last updated 2 Aug 2019.
Clinical trials
- Gut Microbiome and Ventricular Arrhythmias
Sponsor: North Florida Foundation for Research and Education
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20255 payments
- Medtronic, Inc.Program year20256 payments
- Boston Scientific CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.2%Beta blocker38.4%Metoprolol Succinate52%Metoprolol Tartrate38%Sotalol11%Part D<11 patientsAntiarrhythmic19.8%Amiodarone Hcl42%Dofetilide35%Flecainide Acetate23%Part D<11 patients+ 3 more classes in this area
Blood & clotting
22.8%Factor Xa inhibitor22.8%Eliquis82%Xarelto18%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-10973-ACC CHARGE FORWARD: A CASE OF PREMATURE LEADLESS PACEMAKER BATTERY DEPLETION PROMPTING PROACTIVE SURVEILLANCE
Journal of the American College of Cardiology
2026 - Sleep Apnea and Arrhythmias: Those Who Cannot Change Their Minds Cannot Change Anything
Cardiovascular Innovations and Applications
2026 - 26-CCC-11657-ACC DON'T GET UNDER MY SKIN: WHEN TO AVOID SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN THE TREATMENT OF VENTRICULAR TACHYCARDIA
Journal of the American College of Cardiology
2026 - Potential role of gut microbiota in cardiac arrhythmias
American Heart Journal Plus Cardiology Research and Practice
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”